Clinical trial

HuMax-CD20 in Active Rheumatoid Arthritis, Phase I/II

NCT00291928

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-02-01

PhasePHASE2

Study timeline

Study start (unknown)2005-02-01Date precision: month

Registry last updated2012-11-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Arthritis, Rheumatoidunresolved

Interventions

Part ADRUG

Part BDRUG

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00291928 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.